ASCO/EHA/ICML 2021 – Matthew Davids

Matthew Davids depicts the most interesting trial results in the field of CLL treatment at the EHA 2021 congress, gives an outlook on the most promising agents currently tested for use not only in elderly but also in young, fit CLL patients and talks about combinations that might be implemented as pillars of CLL treatment based on current trials.

Here is the full ASCO/EHA/ICML 2021 report.

More posts